title: [Programs for continuing medical education: a session: 4. The pathogenesis and update for the treatments of Parkinson's disease].
authors.forename: Nobutaka
authors.initials: N
authors.lastname: Hattori
mesh_terms: D001545:Benserazide / Q000008:administration & dosage; D052160:Benzothiazoles / Q000008:administration & dosage; D002396:Catechols / Q000008:administration & dosage; D002940:Circadian Rhythm; D003704:Dementia; D018491:Dopamine Agonists / Q000008:administration & dosage; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D020820:Dyskinesias; D004502:Education, Medical, Continuing; D006212:Hallucinations; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D009570:Nitriles / Q000008:administration & dosage; D010300:Parkinson Disease / Q000145:classification / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D000077487:Pramipexole; D012015:Reference Standards; D012017:Referral and Consultation
chemical_list: D052160:Benzothiazoles; D002396:Catechols; D018491:Dopamine Agonists; D004338:Drug Combinations; D009570:Nitriles; C005177:benserazide, levodopa drug combination; D007980:Levodopa; C071192:entacapone; D001545:Benserazide; D000077487:Pramipexole